DHR vs META: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Meta Platforms, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
Meta Platforms, Inc. · Communication Services
$577.22
+33.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
META has more upside to fair value
(+33.9%).
META trades at a lower forward P/E
(20.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
META |
| Current Price |
$177.17 |
$577.22 |
| Fair Value Estimate |
$192.90 |
$772.86 |
| Upside to Fair Value |
+8.9%
|
+33.9%
|
| Market Cap |
$125.4B |
$1,465.2B |
| Forward P/E |
34.1x
|
20.6x
|
| EV / EBITDA |
20.8x
|
13.5x
|
| Price / Sales |
5.1x
|
6.8x
|
| Price / FCF |
23.7x
|
30.4x
|
| Revenue Growth YoY |
+3.7%
|
+33.1%
|
| Gross Margin |
60.7%
|
81.9%
|
| Operating Margin |
21.0%
|
41.2%
|
| Return on Equity |
7.1%
|
33.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
3.29%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Meta Platforms, Inc. operates a dominant family of apps generating nearly all its revenue from advertising, supported by a massive user base and strong network effects. The company exhibits high business quality with 33.2% ROE, 33.1% revenue growth in the most recent quarter, and 60.9% earnings growth in the most recent quarter, reflecting robust profitability and growth. Despite these strengths,…
Accumulation Zones
| Metric |
DHR |
META |
| Zone Low |
$144.68 |
$579.64 |
| Zone High |
$163.97 |
$656.93 |
| In Buy Zone? |
No
|
Yes
|